Novartis Opts For OTC Recall, With J&J/McNeil Lessons Still Fresh
This article was originally published in The Tan Sheet
Executive Summary
After shuttering its Lincoln, Neb., OTC facility, the firm recalls some lots of Bufferin, Excedrin, Gas-X and NoDoz. FDA found a “pattern of problems” when inspecting the plant in 2011, and Novartis’ actions suggest it seeks to avoid the same scrutiny that Johnson & Johnson’s OTC recalls elicited.